Westlake Chemical Corporation 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by Westlake Chemical Corporation on August 17, 2007. The filing addresses Item 5.02 regarding the departure of directors, election of directors, appointment of officers, and compensatory arrangements of certain officers. Specifically, the Board of Directors approved changes to the cash compensation and equity awards for non-management directors effective October 1, 2007.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on director compensation adjustments.
Material Changes
The Board of Directors implemented the following changes to director compensation:
- Cash Compensation: Annual cash compensation for directors is set at $55,000. Additional fees are awarded for committee chairmanships: $12,500 for the Audit Committee chair and $7,500 for the Nominating and Governance or Compensation Committee chairs.
- Stock Options: Each director received an award of 1,920 stock options. The exercise price is $27.125 per share, based on the average high and low trading prices on August 17, 2007. Options vest in 25% annual installments from 2008 to 2011 and expire on August 17, 2017.
- Restricted Stock: Each director received an award of 922 shares of restricted stock. These shares vest in three equal installments (1/3) on August 17, 2008, 2009, and 2010, contingent on continuous service. Unvested shares carry voting rights and dividend entitlements.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on operations, risks, contingencies, or unusual items. The awards were granted pursuant to the Company's 2004 Omnibus Incentive Plan.
Investor Verification Checklist
- Verify the total number of non-management directors to calculate the aggregate cost of the new compensation package.
- Confirm the impact of the $27.125 exercise price relative to the current market price of Westlake Chemical common stock.
- Review the 2004 Omnibus Incentive Plan to ensure the grants comply with plan limits and shareholder approvals.
- Check subsequent filings for any changes to the vesting schedule or forfeiture conditions.